Cargando…
Targeting epidermal fatty acid binding protein for treatment of experimental autoimmune encephalomyelitis
BACKGROUND: Multiple sclerosis (MS) is an autoimmune disease in which dysregulated immune cells attack myelin in the central nervous system (CNS), leading to irreversible neuronal degeneration. Our previous studies have demonstrated that epidermal fatty acid binding protein (E-FABP), widely expresse...
Autores principales: | Rao, Enyu, Singh, Puja, Li, Yan, Zhang, Yuwen, Chi, Young-In, Suttles, Jill, Li, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427938/ https://www.ncbi.nlm.nih.gov/pubmed/25962726 http://dx.doi.org/10.1186/s12865-015-0091-2 |
Ejemplares similares
-
Inhibition of tumor growth by a newly-identified activator for epidermal fatty acid binding protein
por: Rao, Enyu, et al.
Publicado: (2015) -
AMPK-dependent and independent effects of AICAR and compound C on T-cell responses
por: Rao, Enyu, et al.
Publicado: (2016) -
Deficiency of AMPK in CD8(+) T cells suppresses their anti-tumor function by inducing protein phosphatase-mediated cell death
por: Rao, Enyu, et al.
Publicado: (2015) -
Phenethyl Ester of Gallic Acid Ameliorates Experimental Autoimmune Encephalomyelitis
por: Stegnjaić, Goran, et al.
Publicado: (2022) -
Amelioration of Experimental Autoimmune Encephalomyelitis by Anatabine
por: Paris, Daniel, et al.
Publicado: (2013)